Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The price of Novo Nordisk A/S ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 4.015% | 4.015% | -58.088% | -66.206% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)